Reunert Ltd buy krebskrebs
Start price
30.11.20
/
50%
€2.14
Target price
30.11.21
€3.00
Performance (%)
22.43%
End price
01.12.21
€2.62
Summary
This prediction ended on 01.12.21 with a price of €2.62. The BUY prediction by krebskrebs finished with a performance of 22.43%. Dividends of €0.11 are taken into consideration when calculating the performance. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Reunert Ltd | -1.333% | -1.333% | 4.225% | 7.246% |
| iShares Core DAX® | -2,80 % | -1,40 % | -0,22 % | 48,43 % |
| iShares Nasdaq 100 | -6,35 % | -0,41 % | 29,00 % | 84,28 % |
| iShares Nikkei 225® | -6,94 % | -0,28 % | 48,21 % | 59,28 % |
| iShares S&P 500 | -3,41 % | 0,40 % | 20,28 % | 62,51 % |
Comments by krebskrebs for this prediction
In the thread Reunert Ltd diskutieren
In the thread Trading Reunert Ltd
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten